These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38644198)

  • 21. Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor.
    Uchinoumi H; Yano M; Suetomi T; Ono M; Xu X; Tateishi H; Oda T; Okuda S; Doi M; Kobayashi S; Yamamoto T; Ikeda Y; Ohkusa T; Ikemoto N; Matsuzaki M
    Circ Res; 2010 Apr; 106(8):1413-24. PubMed ID: 20224043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia.
    Marks AR; Priori S; Memmi M; Kontula K; Laitinen PJ
    J Cell Physiol; 2002 Jan; 190(1):1-6. PubMed ID: 11807805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Divergent regulation of ryanodine receptor 2 calcium release channels by arrhythmogenic human calmodulin missense mutants.
    Hwang HS; Nitu FR; Yang Y; Walweel K; Pereira L; Johnson CN; Faggioni M; Chazin WJ; Laver D; George AL; Cornea RL; Bers DM; Knollmann BC
    Circ Res; 2014 Mar; 114(7):1114-24. PubMed ID: 24563457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dantrolene rescues aberrant N-terminus intersubunit interactions in mutant pro-arrhythmic cardiac ryanodine receptors.
    Seidel M; Thomas NL; Williams AJ; Lai FA; Zissimopoulos S
    Cardiovasc Res; 2015 Jan; 105(1):118-28. PubMed ID: 25411383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism underlying catecholaminergic polymorphic ventricular tachycardia and approaches to therapy.
    Watanabe H; Knollmann BC
    J Electrocardiol; 2011; 44(6):650-5. PubMed ID: 21872879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ryanodine receptor-targeted anti-arrhythmic therapy.
    Wehrens XH; Lehnart SE; Marks AR
    Ann N Y Acad Sci; 2005 Jun; 1047():366-75. PubMed ID: 16093511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenic mechanism of a catecholaminergic polymorphic ventricular tachycardia causing-mutation in cardiac calcium release channel RyR2.
    Xiong J; Liu X; Gong Y; Zhang P; Qiang S; Zhao Q; Guo R; Qian Y; Wang L; Zhu L; Wang R; Hao Z; Wen H; Zhang J; Tang K; Zang WF; Yuchi Z; Chen H; Chen SRW; Zheng W; Wang SQ; Xu YW; Liu Z
    J Mol Cell Cardiol; 2018 Apr; 117():26-35. PubMed ID: 29477366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of a novel mutation in the cardiac ryanodine receptor that results in catecholaminergic polymorphic ventricular tachycardia.
    Jiang D; Jones PP; Davis DR; Gow R; Green MS; Birnie DH; Chen SR; Gollob MH
    Channels (Austin); 2010; 4(4):302-10. PubMed ID: 20676041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-β-blocking R-carvedilol enantiomer suppresses Ca2+ waves and stress-induced ventricular tachyarrhythmia without lowering heart rate or blood pressure.
    Zhang J; Zhou Q; Smith CD; Chen H; Tan Z; Chen B; Nani A; Wu G; Song LS; Fill M; Back TG; Chen SR
    Biochem J; 2015 Sep; 470(2):233-42. PubMed ID: 26348911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for Novel Type 2 Ryanodine Receptor Inhibitors by Endoplasmic Reticulum Ca
    Takenaka M; Kodama M; Murayama T; Ishigami-Yuasa M; Mori S; Ishida R; Suzuki J; Kanemaru K; Sugihara M; Iino M; Miura A; Nishio H; Morimoto S; Kagechika H; Sakurai T; Kurebayashi N
    Mol Pharmacol; 2023 Dec; 104(6):275-286. PubMed ID: 37678938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nebivolol suppresses cardiac ryanodine receptor-mediated spontaneous Ca2+ release and catecholaminergic polymorphic ventricular tachycardia.
    Tan Z; Xiao Z; Wei J; Zhang J; Zhou Q; Smith CD; Nani A; Wu G; Song LS; Back TG; Fill M; Chen SR
    Biochem J; 2016 Nov; 473(22):4159-4172. PubMed ID: 27623776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of ryanodine receptor function prolongs Ca2+ release refractoriness and promotes cardiac alternans in intact hearts.
    Zhong X; Sun B; Vallmitjana A; Mi T; Guo W; Ni M; Wang R; Guo A; Duff HJ; Gillis AM; Song LS; Hove-Madsen L; Benitez R; Chen SR
    Biochem J; 2016 Nov; 473(21):3951-3964. PubMed ID: 27582498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Calmodulin Variant p.E46K Associated With Severe Catecholaminergic Polymorphic Ventricular Tachycardia Produces Robust Arrhythmogenicity in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Gao J; Makiyama T; Yamamoto Y; Kobayashi T; Aoki H; Maurissen TL; Wuriyanghai Y; Kashiwa A; Imamura T; Aizawa T; Huang H; Kohjitani H; Nishikawa M; Chonabayashi K; Fukuyama M; Manabe H; Nakau K; Wada T; Kato K; Toyoda F; Yoshida Y; Makita N; Woltjen K; Ohno S; Kurebayashi N; Murayama T; Sakurai T; Horie M; Kimura T
    Circ Arrhythm Electrophysiol; 2023 Mar; 16(3):e011387. PubMed ID: 36866681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CPVT-associated cardiac ryanodine receptor mutation G357S with reduced penetrance impairs Ca2+ release termination and diminishes protein expression.
    Liu Y; Wei J; Wong King Yuen SM; Sun B; Tang Y; Wang R; Van Petegem F; Chen SRW
    PLoS One; 2017; 12(9):e0184177. PubMed ID: 28961276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How does flecainide impact RyR2 channel function?
    Salvage SC; Huang CL; Fraser JA; Dulhunty AF
    J Gen Physiol; 2022 Sep; 154(9):. PubMed ID: 35713932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sudden death after inappropriate shocks of implantable cardioverter defibrillator in a catecholaminergic polymorphic ventricular tachycardia case with a novel RyR2 mutation.
    Itoh H; Murayama T; Kurebayashi N; Ohno S; Kobayashi T; Fujii Y; Watanabe M; Ogawa H; Anzai T; Horie M
    J Electrocardiol; 2021; 69():111-118. PubMed ID: 34656916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia.
    Song L; Alcalai R; Arad M; Wolf CM; Toka O; Conner DA; Berul CI; Eldar M; Seidman CE; Seidman JG
    J Clin Invest; 2007 Jul; 117(7):1814-23. PubMed ID: 17607358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel ryanodine receptor mutation linked to sudden death increases sensitivity to cytosolic calcium.
    Meli AC; Refaat MM; Dura M; Reiken S; Wronska A; Wojciak J; Carroll J; Scheinman MM; Marks AR
    Circ Res; 2011 Jul; 109(3):281-90. PubMed ID: 21659649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak.
    Lehnart SE; Wehrens XH; Laitinen PJ; Reiken SR; Deng SX; Cheng Z; Landry DW; Kontula K; Swan H; Marks AR
    Circulation; 2004 Jun; 109(25):3208-14. PubMed ID: 15197150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss-of-function mutations in cardiac ryanodine receptor channel cause various types of arrhythmias including long QT syndrome.
    Hirose S; Murayama T; Tetsuo N; Hoshiai M; Kise H; Yoshinaga M; Aoki H; Fukuyama M; Wuriyanghai Y; Wada Y; Kato K; Makiyama T; Kimura T; Sakurai T; Horie M; Kurebayashi N; Ohno S
    Europace; 2022 Mar; 24(3):497-510. PubMed ID: 34661651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.